| Recruiting | Treatment and Mapping of Impostor Phenomenon NCT05805696 | Umeå University | N/A |
| Unknown | Methotrexate Iontophoresis Versus Coal Tar Ointement in the Treatment of Primary Palmer Hyper Hidrosis NCT05875285 | Cairo University | N/A |
| Withdrawn | miraDry Post Market Tumescent Anesthesia Study NCT05546710 | miraDry, Inc. | N/A |
| Recruiting | Topical Oxybutynin for Treatment of Hyperidrosis: Local or Systemic Effect? NCT05102396 | Samantha Rodrigues Camargo Neves de Moura | Phase 2 |
| Completed | Thoracoscopic Sympathetic Chain Interruption for Palmar Hyperhidrosis in Patients Below 18 NCT06113978 | dr. Muhammad Abdelhafez Mahmoud, MD | N/A |
| Completed | Antiperspirant in the Treatment of Residual Limp Hyperhidrosis for Prosthetic Users NCT05501444 | Sophies Minde Ortopedi | N/A |
| Recruiting | Botulinum Toxin Therapy in Hidradenitis Suppurativa NCT05403710 | University of Massachusetts, Worcester | — |
| Completed | Qbrexza Cloths for Hyperhidrosis of Amputation Sites NCT04924036 | University of Utah | Phase 2 |
| Completed | Determination of Longus Colli Muscle Thickness by Ultrasonography NCT05108103 | Istanbul University | — |
| Completed | Laser Acupuncture Versus Tap Water Iontophoresis on Hyperhidrosis NCT04862546 | Kafrelsheikh University | N/A |
| Completed | An Open Label Study for Palmar Hyperhydrosis NCT04906655 | Pariser, Robert J., M.D. | Phase 2 |
| Completed | Implementation of a Minor Ailment Service in Community Pharmacy Practice NCT05247333 | Universidad de Granada | N/A |
| Unknown | Clinical Study to Assess the Efficacy and Safety of AT-5214 in the Treatment of Subjects With Palmar Hyperhidr NCT04263623 | Atacama Therapeutics | Phase 2 |
| Completed | Hyperhidrosis in Patients With Amputations-Botox NCT03236012 | University of Utah | Phase 1 |
| Completed | Assessing the Effect of Patient Characteristics on Treatment Response in Primary Hyperhidrosis NCT03694093 | St. Louis University | — |
| Completed | Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2 NCT03416348 | University of Utah | Phase 1 |
| Completed | Hyperhydrosis Treatment Using Botulinum Toxin NCT03816046 | St Joseph University, Beirut, Lebanon | Phase 4 |
| Completed | Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers NCT03647982 | Medy-Tox | Phase 1 |
| Completed | A Confirmatory Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis NCT03024255 | Botanix Pharmaceuticals | Phase 2 |
| Unknown | Image Guided Targeted Photoablation for the Treatment of Localized Hyperhidrosis NCT04178161 | Massachusetts General Hospital | N/A |
| Completed | Management of Palmar Hyperhidrosis With Hydrogel-based Iontophoresis NCT02854540 | Stanford University | N/A |
| Completed | T3-T4 Gray Sympathycotomy Versus Ramicotomy for Hyperhidrosis NCT04721483 | University of Valencia | N/A |
| Completed | A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis NCT02682238 | Botanix Pharmaceuticals | Phase 2 |
| Completed | A Study to Evaluate Clinical Effect, Pharmacokinetics , Safety, and Tolerability of Umeclidinium in Palmar Hyp NCT02673619 | Stiefel, a GSK Company | Phase 2 |
| Completed | Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower NCT03433859 | Direction Centrale du Service de Santé des Armées | Phase 3 |
| Completed | A Pilot Study Exploring the Efficacy and Safety of Topical Oxybutynin 3% Gel for Primary Focal Hyperhidrosis i NCT02633371 | University of Colorado, Denver | N/A |
| Withdrawn | Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis NCT02099695 | Cristália Produtos Químicos Farmacêuticos Ltda. | Phase 3 |
| Completed | Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhi NCT02563899 | GlaxoSmithKline | Phase 2 |
| Completed | A Non-Interventional Study To Assess Sweating NCT02552199 | Botanix Pharmaceuticals | — |
| Completed | Safety and Efficacy of Botulinum Toxin Type A Topical Gel for Primary Axillary Hyperhidrosis NCT02565732 | Revance Therapeutics, Inc. | Phase 2 |
| Completed | Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis NCT02553798 | Journey Medical Corporation | Phase 3 |
| Completed | Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis NCT02530294 | Journey Medical Corporation | Phase 3 |
| Completed | Study of Glycopyrronium in Axillary Hyperhydrosis NCT02530281 | Journey Medical Corporation | Phase 3 |
| Completed | Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary Hyperhidrosis NCT02479139 | Allergan | Phase 2 |
| Completed | The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar. NCT02973659 | Tel-Aviv Sourasky Medical Center | N/A |
| Completed | A Safety and Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis NCT02336503 | Botanix Pharmaceuticals | Phase 2 |
| Completed | The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis NCT03203174 | University of California, Davis | Phase 1 |
| Completed | Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis NCT02129660 | Journey Medical Corporation | Phase 2 |
| Completed | A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis NCT02058264 | Botanix Pharmaceuticals | Phase 1 |
| Completed | Safety and Efficacy of an Anticholinergic Agent for Treatment of Primary Axillary Hyperhidrosis NCT02193139 | Watson Pharmaceuticals | Phase 2 |
| Completed | A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis NCT02016885 | Journey Medical Corporation | Phase 2 |
| Completed | Characterization of Exposure From Topical Administration of [14C] Umeclidinium to Axilla or Palm of Healthy Ma NCT01934153 | GlaxoSmithKline | Phase 1 |
| Unknown | Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis NCT01930604 | Carl Swartling | Phase 2 |
| Completed | Treatment of Hyperhidrosis With Oxybutynin NCT01855256 | University Hospital, Brest | Phase 3 |
| Completed | Evaluation of 1440nm Laser Assisted Selective Photothermolysis for Treatment of Axillary Hyperhidrosis NCT02100072 | Cynosure, Inc. | N/A |
| Completed | Evaluation of 1440nm Laser vs. Botulinum Toxin or miraDry® Microwave For Treatment of Axillary Hyperhidrosis NCT01811004 | Cynosure, Inc. | N/A |
| Completed | Histological Analysis Following Ulthera System Treatment for Hyperhidrosis NCT01708551 | Ulthera, Inc | N/A |
| Completed | Investigation of Hyperhidrosis Treatment Using the Nd: YAG 1440nm Wavelength Laser NCT01810991 | Cynosure, Inc. | N/A |
| Completed | Cardiac Autonomic Changes After Endoscopic Thoracic Sympathectomy For Essential Palmar Hyperhidrosis NCT02733497 | University of Campania Luigi Vanvitelli | N/A |
| Completed | Feasibility Study: Safety and Efficacy of the Ulthera® System for Treatment of Axillary Hyperhidrosis NCT01713673 | Ulthera, Inc | N/A |
| Completed | Feasibility Study: Ulthera® System for the Treatment of Axillary Hyperhidrosis NCT01713959 | Ulthera, Inc | N/A |
| Completed | Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study NCT01310712 | University of Sao Paulo | Phase 4 |
| Completed | GSK1358820 (Botulinum Toxin A) PhIII DB & OL Study in Patients With Axillary Hyperhidrosis NCT01128738 | GlaxoSmithKline | Phase 3 |
| Completed | A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar Hyperhidrosis NCT01328015 | Federal University of São Paulo | Phase 2 |
| Completed | Staged Extended Thoracoscopic Sympathicotomy for Palmo-axillo-plantar Hyperhidrosis NCT02728297 | Mansoura University | N/A |
| Completed | Study to Assess the Efficacy of Botulinum Toxin B (Myobloc) for the Treatment of Prosthesis-associated Sweatin NCT01671800 | Henry M. Jackson Foundation for the Advancement of Military Medicine | Phase 1 |
| Completed | Safety and Efficacy of BOTOX® (Botulinum Toxin Type A) in Korea NCT02043145 | Allergan | — |
| Completed | Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis NCT01956591 | Hospital Israelita Albert Einstein | — |
| Completed | Non-prescription Versus Prescription Topical Treatments Versus no Treatment in the Control of Sweating NCT00509886 | Northwestern University | N/A |
| Completed | Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin NCT00449683 | Thomas Jefferson University | Phase 4 |
| Completed | Objective Evaluation of Patients With Palmar Hyperhidrosis Submitted to Two Levels of Sympathectomy: T3 and T4 NCT01140659 | University of Sao Paulo | N/A |
| Completed | A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis NCT00168415 | Allergan | Phase 4 |
| Completed | A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis NCT00168480 | Allergan | Phase 4 |
| Completed | A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis NCT00168402 | Allergan | Phase 3 |
| Completed | Study of Botulinum Toxin in Patients With Primary Hyperhidrosis NCT00004480 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | Liposuction as Treatment for Excessive Axillary Sweat NCT00228072 | Odense University Hospital | Phase 2 / Phase 3 |